Page numbers followed by “f” indicate figures.
Page numbers followed by “t” indicate tables.
R group, 42, 43f
R7 photoreceptors, 740–741, 740f
Rab effector proteins, 644
Rab GTPases, 641–642
Rab proteins, 289, 641, 644
Rab-
Rabies virus, 1083
Rac, 813–816, 816f
Radial glial cells (RGCs), 1032f
Radiant energy, 57
Radiation
DNA damage from, 203–204
double-
p53 and exposure to, 1165
thymine-
Radioisotopes, 114–116, 114f
Radiolabeling, 684
Raf, 742, 744
RAG1 recombinase, 1098, 1098f, 1118
RAG2 recombinase, 1098, 1098f, 1118
“Ragged-
Ramón y Cajal, Santiago, 1070, 1071f
Ran protein, 624–625, 854
Random coil, 70
Ran-
Ran-
Ran-
Ran-
Ranitidine, 687t
RAP1 protein, 391, 393
RAR. See Retinoic acid receptor
RARE. See Retinoic acid response element
Ras, 289, 325, 739, 743f
cancer development and, 739, 1146, 1148, 1155, 1160
RTKs and, 741–742, 741f
signals passing from, 742, 744
Ras/MAP kinase pathway, 739–748, 743f
Rate constant, 52
Rate-
RB gene, 1153
Rb (retinoblastoma) protein, 889
RBD. See Rho-
Reaction center, 563
Reactions
aerobic, 63
chemical, 51–57
chromogenic enzyme, 111
dehydration, 41
endergonic, 58, 59f
endothermic, 59
exergonic, 58, 59f
exothermic, 59
peptidyltransferase, 194
rate of, 60–61
redox, 63
transesterification, 423, 425f, 466
Reactive oxygen species (ROS), 547–549, 548f
protection in photoelectron transport from, 570
Reading frame, 184, 185f
Rec8, 916
Receptor hetero-
Receptor homodimerization, 728
Receptor neurons, 1028
Receptor proteins, 271
activation of, 682
affinity for ligands, 681–682, 682f
binding specificity of, 676
purification with affinity chromatography, 683–684
response to signaling molecules and activation of, 682
Receptor serine kinases, 722–726
Receptor tyrosine kinases (RTKs), 726, 727f, 734–738, 1159
dimerization of, 734–735
I-
down-
general structure and activation of, 734–735, 734f
intrinsic tyrosine kinase activation, 734–735
lysosomal degradation of, 738
Ras and, 741–742, 741f
Receptor-
adenylyl cyclase stimulating and inhibiting, 699–701, 700f
binding assays and, 681–682
dissociation constant of, 681
endosome pH and dissociation of, 662–663
stability of, 681
Receptor-
Receptors. See also Cell-
cytokine, 726–733, 727f, 729f, 733f
nuclear, 386, 400–402, 400f, 401f, 403f
Recessive alleles, 224–225
monogenic diseases and, 255
Recessive lethal mutations, 228
Recessive mutant alleles, 225, 225f
Recessive mutations
autosomal, 621
complementation tests of, 229–230
lethal, 621
Reclinomonas americana, 527
Recognition helix, 384
Recombinant DNA, 234
techniques, 28
Recombinant types, 232
Recombination, 209, 232
DNA, 203–212, 211f
exon shuffling by, 321f
homologous, 260, 260f, 907, 911, 912
during meiosis, 233
somatic, 1095
somatic cell, 261–262
Recombination signal sequences (RSS), 1098, 1098f, 1099
Red blood cells, formation of, 728f
Redox reactions, 63
Reduction, 63
Reduction potential, 64, 546
Redundant proteins, 231–232, 232f
REF. See RNA export factor
Reflex arc, 1029
Reflexes, 1029, 1030f
Refractive index, 141
Refractory period, 1036, 1038
Regulated cell death, 1011–1022
Regulated intramembrane proteolysis, 607, 764
Regulated secretion, 632
Regulators of G protein signaling (RGSs), 678, 690
Regulatory light chain, 797
Regulatory proteins, 68
Regulatory sequences, 378–389
Regulatory signals
extrinsic, 989
intrinsic, 988
stem cells and, 988–989
Rehydration therapy, 509
Release factors (RFs), 195
Remodeling, 510
chromatin-
ECM, 960
mRNP, 441, 441f
Renaturation, 173–174
Reoviruses, 967
Repetitious DNA, 301, 310
Replication
of bacteria, 1081
chromosome, 345, 346f
regulation of, 339
of viruses, 1081
Replication factor C (RFC), 200–201
Replication fork, 199
collapsed, repair of, 209–210, 210f
Replication origins, 199, 345
Replication protein A (RPA), 201
Replicative helicase, 199
Replicative senescence, 880
Repolarization, 1028
Reporter gene, 364
Repression domain, 384, 386–387
Repressor proteins, 354, 364
histone deacetylation directed by, 393–394
Repressors, 383–384, 384f
splicing, 437–439
Residues, 42
Resonance hybrids, 36
Resonance transfer, 566
Respiration, 62–63, 515
aerobic, 513, 515
anaerobic, 515
cellular, 63
photorespiration, 576–578, 576f
Respiratory chain, 539
Respiratory control, 558
Response elements, 400, 401f, 402
Response regulator, 361, 361f
Resting K+ channel, 497, 498f
Resting membrane potential, 495–501, 1034
K+ channels and, 495
Resting potential, 1027
Restriction elements, 1105
Restriction enzymes, 234–236, 235f, 235t
Restriction fragments, 235, 236, 236f
Restriction point, 875, 888–889, 1164, 1164f
Retinitis pigmentosa, 258
Retinoblastoma, 725, 1153, 1153f, 1164
Retinoblastoma protein. See Rb (retinoblastoma) protein
Retinoic acid receptor (RAR), 912
Retinoic acid response element (RARE), 401f, 402
Retrograde transport vesicles, 632
Retroposed RNAs, 321
Retrotransposons, 313, 313f, 322
LTR, 316, 316f, 317f, 318
non-
Retroviral DNA, 316, 316f
Retroviral expression systems, 252, 252f
Retroviral genomic RNA, 316, 316f
Retroviruses, 216–218, 217f, 445
budding, 666–667, 668f
oncogenic, 217
slow-
Retrovirus-
Rev protein, 444–445, 444f
Reverse transcriptase, 217, 313, 316, 317f
Reverse transcriptase-
Rev-
RFC. See Replication factor C
RFs. See Release factors
RGCs. See Radial glial cells
RGD motif, 938
RGG box, 422
RGSs. See Regulators of G protein signaling
Rhabdomyosarcoma, 757
Rheb GTPase, 453f
Rheb-
Rheumatoid arthritis, 681
Rhinoviruses (RV), 936–937
Rho, 813–816, 816f
Rho kinase, 808
Rho-
Rhodopsin, 694f, 695f
activation of, 695–696, 696f
arrestin binding and, 697–698
phosphorylation of, 697–698
signal amplification in transduction pathway, 696–697
Rhodopsin kinase, 697, 697f
Rhodopsin signal transduction pathway
amplification in, 696–697
termination of, 697–698, 697f
Rho-
Ribonucleic acid (RNA), 8–9, 45, 168, 420t
alternative splicing, 181–182, 182f
conformations and functions of, 174–175
5′ capping, 420–421, 421f
hydrolysis of, 172, 173f
noncoding, 14
nuclear exoribonucleases degrading, 432
retroposed, 321
roles in protein synthesis, 183, 183f
secondary and tertiary structures, 175, 175f
self-
synthesis of, 177f
as transposition intermediate, 318, 318f
Ribonucleoprotein complexes (RNP complexes), 419
Ribonucleoside triphosphate (rNTP), 177f
Ribonucleoside triphosphate monomers (rNTPs), 169f
Ribosomal RNA (rRNA), 14, 167f, 168, 169f, 183
processing of, 461–469
protein synthesis role, 183, 183f
tandemly repeated genes for, 307–308
Ribosomes, 8
antibiotics and, 190
bacterial, 189f
common components, 189t
common core structure, 190f
mitochondrial, 526–527
I-
protein synthesis on, 188–197
recycling, 195
subunit assembly, 464–465, 465f
Riboswitches, 362, 363f
Ribozymes, 8, 90, 175
Ribulose 1,5-
Rickettsiaceae group, 527
RIG-
Rigid cell walls, 968
RIM, 1056
RIM-
RIP1, 1022
RIP3, 1022
RISC. See RNA-
Risperidone, 687t
RNA. See Ribonucleic acid
RNA editing, 439–440, 440f
RNA export factor (REF), 427, 441
RNA helicase, 191, 192f
RNA interference (RNAi), 95, 264–266, 265f, 419, 450–451, 1158
RNA knockdown, 419
RNA polymerase B (RPB), 368f, 369, 369f
RNA polymerase I (Pol I), 367, 367f, 461
transcription initiation by, 412–413, 412f
RNA polymerase II (Pol II), 367–370, 367f, 391
chain elongation by, 428, 428f
distant enhancers and transcription of, 379
5′ capping and, 420–421
general transcription factors, 373–376
Mediator complex and, 396–397
metazoan regulation of, 402
polyadenylation signal and, 431–432
preinitiation complex, 374, 375f
promoters, 371–373
transcription initiation, 371
RNA polymerase III (Pol III), 367, 367f, 391, 461
transcription initiation by, 413–414, 413f
RNA polymerases, 8, 9f
bacterial classes of, 368, 368f
eukaryote classes of, 367–370, 367f, 367t, 368f
mRNA synthesis initiation, 353
precursor mRNAs and, 180
structure of, 178–179, 179f
in transcription, 176–179, 177f
transcription initiation by, 357
RNA processing, 169f, 180, 181f, 418f, 419
metazoans and, 432–433
RNA recognition motif (RRM), 422, 423f
RNA splicing, 181, 419, 423–424, 424f, 426f
alternative, 181–182, 182f, 417, 438, 438t–439t
base pairing during, 424, 425f, 426
pre-
snRNAs in, 424, 425f, 426
spliceosome carrying out, 426–428, 427f
RNA viruses, 212, 967
RNA world hypothesis, 8
RNA-
RNA-
RNA-
RNAi. See RNA interference
RNA-
RNA-
RNase P, 467
RNP complexes. See Ribonucleoprotein complexes
rNTP. See Ribonucleoside triphosphate
Rod cells, 694–695, 694f, 1061
visual adaptation and, 698
Root apical meristem, 997, 998f, 999
ROS. See Reactive oxygen species
Rough endoplasmic reticulum, 13f, 16, 16f
N-linked oligosaccharide synthesis and, 601–602, 602f, 603f
in secretory pathway, 632
secretory proteins and, 587f
structure of, 586, 586f
Roundworm. See Caenorhabditis elegans
Rous sarcoma virus (RSV), 1152
RPA. See Replication protein A
RPB. See RNA polymerase B
RPB1, 369, 369f
RPB2, 369
RRE. See Rev-
RRM. See RNA recognition motif
rRNA. See Ribosomal RNA
R-
RSS. See Recombination signal sequences
RSV. See Rous sarcoma virus
RTK/RAS/MAP kinase pathway, 1160
RTKs. See Receptor tyrosine kinases
RT-
rtTA, 1148
Rubisco, 573, 574f
Rubisco activase, 574, 576
RV. See Rhinoviruses
RV-
RXR-